Denenicokin
Denenicokin Uses, Dosage, Side Effects, Food Interaction and all others data.
Denenicokin is under investigation in clinical trial NCT01152788 (Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma).
| Trade Name | Denenicokin |
| Generic | Denenicokin |
| Denenicokin Other Names | Denenicokin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Denenicokin
